Table 4.
Methodological Quality Measurement of the Included Pre and Post Intervention Studies
| MINORS items | Reported and adequate |
|---|---|
| A clearly stated aim | Burton et al., 2010; Chang et al., 2003; Kwong et al., 2009; Lau et al., 2020; Ma et al., 2004; Shelley et al., 2008; Shelley et al., 2010 |
| Inclusion of consecutive patients | Burton et al., 2010; Chang et al., 2003; Kwong et al., 2009; Lau et al., 2020; Ma et al., 2004; Shelley et al., 2008; Shelley et al., 2010 |
| Prospective collection of data | Burton et al., 2010; Kwong et al., 2009; Lau et al., 2020; Ma et al., 2004; Shelley et al., 2008; Shelley et al., 2010 |
| Endpoints appropriate to the aim of the study | Burton et al., 2010; Chang et al., 2003; Kwong et al., 2009; Lau et al., 2020; Ma et al., 2004; Shelley et al., 2008; Shelley et al., 2010 |
| Unbiased assessment of the study endpoint | Burton et al., 2010; Chang et al., 2003; Kwong et al., 2009; Lau et al., 2020; Ma et al., 2004; Shelley et al., 2008; Shelley et al., 2010 |
| Follow-up period appropriate to the aim of the study | Burton et al., 2010; Chang et al., 2003; Kwong et al., 2009; Lau et al., 2020; Ma et al., 2004; Shelley et al., 2008; Shelley et al., 2010 |
| Loss to follow up less than 5% | Chang et al., 2003; Ma et al., 2004 |
| Prospective calculation of the study size | 0 |
| An adequate control group* | Chang et al., 2003 |
| Contemporary groups* | Chang et al., 2003 |
| Baseline equivalence of groups* | Chang et al., 2003 |
| Adequate statistical analyses* | Chang et al., 2003 |
*Only applicable to the quasi-experimental study with a control group.